(19)
(11) EP 2 016 062 A2

(12)

(88) Date of publication A3:
27.03.2008

(43) Date of publication:
21.01.2009 Bulletin 2009/04

(21) Application number: 07755981.3

(22) Date of filing: 25.04.2007
(51) International Patent Classification (IPC): 
C07D 277/20(2006.01)
C07D 333/38(2006.01)
A61K 31/426(2006.01)
C07D 333/36(2006.01)
A61K 31/381(2006.01)
A61P 31/12(2006.01)
(86) International application number:
PCT/US2007/009959
(87) International publication number:
WO 2007/127212 (08.11.2007 Gazette 2007/45)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 25.04.2006 US 795069 P

(71) Applicant: The Cleveland Clinic Foundation
Beachwood, OH 44122 (US)

(72) Inventors:
  • SILVERMAN, Robert
    Beachwood, OH 44121 (US)
  • TORRENCE, Paul
    Williams, OR 97544 (US)
  • JHA, Babal, Kant
    Cleveland, OH 44120 (US)
  • FRANCOM, Paula
    Notting Hill, VIC 3168 (AU)

(74) Representative: Stevens, Ian Edward 
Potter Clarkson LLP Park View House 58 The Ropewalk
Nottingham NG1 5DD
Nottingham NG1 5DD (GB)

   


(54) ANTI-VIRAL AGENTS THAT ACTIVATE RNASE L